As a lifelong advocate for education, I have the privilege of leading Brownsville ISD, where my focus is on providing students with the resources they need to pursue fulfilling careers. In recent...
Sino Land (SNLAY), Two Harbors (TWO) and Grantite Point (GPMT) are three real estate stocks to look into as mortgage rates continue to rise despite Fed rate cuts.
The acquisition of LBC leads to higher NII and non-interest income and a rise in loan balance. These, along with nil provisions, aid WAFDs fiscal Q4 earnings.
Zuora (ZUO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Fifth Third Bancorp (FITB) delivered earnings and revenue surprises of 3.66% and 1.07%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Long-time cash-generating king Apple has recently hit fresh all-time highs, reflecting considerably bullish price action. Should investors take a closer look?
Momentum in cloud computing, IoT, auto and AI is likely to favor the prospects of Zacks Computer - Storage Devices industry players like SMCI, NTAP and PSTG amid macroeconomic headwinds.
OZKs third-quarter 2024 results rise on the back of higher net revenues and rise in loans and deposits. However, a rise in expenses and provisions are woes.
Decent IB fees, NII and trading revenue growth are likely to have aided RJFs fourth-quarter fiscal 2024 earnings, while higher expenses are likely to have hurt.
We have screened bargain stocks PAM, NOMD, KBH, COLB and SLGN based on the EV-to-EBITDA ratio, which gives the true picture of valuation and earnings potential.
American Express (AXP) delivered earnings and revenue surprises of 6.73% and 0.03%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
SLBs Q3 earnings benefit from broad-based growth and margin expansion in the Middle East, Asia and offshore North America, alongside cost optimization and digital solutions.
Despegar.com (DESP) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesnt suggest further strength down the road.
The price-to-sales ratio is a convenient tool to gauge the value of stocks incurring losses or in an early development cycle. Stocks like GIII, BTU, KBH, PAM and MPB hold promise.
Forward Air (FWRD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
CLMT subsidiary Montana Renewables is set to become a world leader in Sustainable Aviation Fuel production, capable of producing 300 million gallons per year.
Amicus Therapeutics (FOLD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
LANSING — Today, Governor Gretchen Whitmer and the Michigan Economic Development Corporation (MEDC) announced business investment and community revitalization projects in Michigan’s Upper Peninsula that will represent over $5.5 million of capital investment and protect 85 high-paying jobs in the region. “Today’s projects will drive more than $5.5 million of investment and protect 85 good-paying jobs in Houghton and Schoolcraft counties,” said Gov. Whitmer. “From an […]
Acme United (ACU) delivered earnings and revenue surprises of -26.03% and 8.08%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
The average of price targets set by Wall Street analysts indicates a potential upside of 57.8% in Legato Merger (ASTL). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Charles River launches Retrogenix Non-Human Protein Library to provide early insights into how therapeutics interact with non-human protein targets in vitro.
PSX plans to shut its Los Angeles refinery by late 2025, citing market dynamics and lower profits, leaving California to face further fuel supply challenges.
With the latest approval, ABBVs Vyalev becomes the first and only subcutaneous 24-hour infusion of levodopa-based therapy for treating advanced Parkinsons disease.
With strong revenue growth in commercial service and government engineering units and an expanding subscriber base, IRDM delivers impressive Q3 performance.